Mechanism of action of favipiravir against SARS-CoV-2: Mutagenesis or chain termination?

• Lei Zhao,
• Wu Zhong

Affiliations

Lei Zhao

National Engineering Research Center for the Emergency Drug, Beijing Institute of Pharmacology and Toxicology, Beijing 100850, China

Wu Zhong

National Engineering Research Center for the Emergency Drug, Beijing Institute of Pharmacology and Toxicology, Beijing 100850, China; Corresponding author